stockrow4D Molecular Therapeutics, Inc. (FDMT) vs Geron Corporation (GERN)
- 4D Molecular Therapeutics, Inc. FDMT 12.32 +9.51%
- Geron Corporation GERN 0.98 +3.16%
4D Molecular Therapeutics, Inc. and Geron Corporation are both Biotechnology companies. 4D Molecular Therapeutics, Inc. and Geron Corporation are of similar size ($621.5M and $610.4M). 4D Molecular Therapeutics, Inc. grew revenue faster over the last twelve months: 278,712.1% against 18.6%. Geron Corporation has the higher net margin (−22.0% vs −194.7%) and the higher return on invested capital (−34.1% vs −186.9%). Across the 18 metrics below, Geron Corporation leads on 12 and 4D Molecular Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | FDMT | GERN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 91.59% | 68.51% |
| Operating margin | (214.24%) | (14.75%) | 0.00% |
| Net margin | (194.74%) | (21.99%) | 0.00% |
| Free cash flow margin | (169.51%) | (41.91%) | 0.00% |
| Return on equity | (43.25%) | (20.12%) | (51.96%) |
| Return on assets | (37.09%) | (8.74%) | (46.06%) |
| Return on invested capital | (186.91%) | (34.12%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack